SCHEMBL4851884

SCHEMBL4851884

c1ccc2c(c1)-c1cccc3c1c-2cc1cc2ccccc2cc13

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.74
HSD17B10 Q99714 6/20 0.74
MAPK1 P28482 4/20 0.74
HPGD P15428 4/20 0.74
TSHR P16473 3/20 0.74
HIF1A Q16665 3/20 0.74
CASP1 P29466 3/20 0.74
L3MBTL1 Q9Y468 2/20 0.74
CASP7 P55210 2/20 0.54
TP53 P04637 1/20 0.54
ATM Q13315 2/20 0.48
HKDC1 Q2TB90 1/20 0.46
CRHBP P24387 1/20 0.44
CRHR2 Q13324 1/20 0.44
KEAP1 Q14145 1/20 0.44
NFE2L2 Q16236 1/20 0.44
CYP1A2 P05177 3/20 0.42
ERBB2 P04626 1/20 0.42
FYN P06241 1/20 0.42
MAOA P21397 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Benzo[B]Fluoranthene SCHEMBL29503670 0.85 ALDH1A1 (1.00) ALDH1A1HSD17B10MAPK1HPGDTSHR
Benzo[B]Fluoranthene SCHEMBL175779 0.85 ALDH1A1 (1.00) ALDH1A1HSD17B10MAPK1HPGDTSHR
Benzo[B]Fluoranthene SCHEMBL29373899 0.85 ALDH1A1 (1.00) ALDH1A1HSD17B10MAPK1HPGDTSHR
Benzo[B]Fluoranthene SCHEMBL30626366 0.85 ALDH1A1 (1.00) ALDH1A1HSD17B10MAPK1HPGDTSHR
SCHEMBL1273375 0.83 ALDH1A1 (0.88) ALDH1A1HSD17B10MAPK1HPGDTSHR
SCHEMBL11299904 0.81 ALDH1A1 (0.50) ALDH1A1HSD17B10MAPK1HPGDTSHR
SCHEMBL29268792 0.80 ALDH1A1 (0.62) ALDH1A1HSD17B10MAPK1HPGDTSHR
SCHEMBL4856726 0.79 ALDH1A1 (0.47) ALDH1A1HSD17B10MAPK1HPGDTSHR
Benzo[B]Fluoranthene SCHEMBL25399455 0.78 ALDH1A1 (0.85) ALDH1A1HSD17B10MAPK1HPGDTSHR
SCHEMBL2861350 0.78 ALDH1A1 (0.52) ALDH1A1HSD17B10MAPK1HPGDTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12227625-B2 Composite materials comprising mechanical ligands NANOCORE APS (DK) 2025-02-18 US disclosed
EP-4119598-A1 NANOCOMPOSITE MATERIALS COMPRISING MECHANICAL LIGANDS Nanocore ApS (DK) 2023-01-18 EP disclosed
EP-3737711-B1 COMPOSITE MATERIALS COMPRISING MECHANICAL LIGANDS NANOCORE APS (DK) 2022-04-06 EP disclosed
EP-3737711-A1 COMPOSITE MATERIALS COMPRISING MECHANICAL LIGANDS Nanocore Aps (DK) 2020-11-18 EP disclosed
US-20200354220-A1 COMPOSITE MATERIALS COMPRISING MECHANICAL LIGANDS NANOCORE APS (DK) 2020-11-12 US disclosed
US-20160141506-A1 NAPHTHO[2,1-b]FLUORANTHENE COMPOUND, ORGANIC LIGHT-EMITTING DEVICE, DISPLAY APPARATUS, LIGHTING APPARATUS, IMAGE FORMING APPARATUS, AND EXPOSING APPARATUS CANON KABUSHIKI KAISHA (JP) 2016-05-19 US disclosed
US-7470290-B2 Hydroscopic polymer gels for easier cleaning THE CLOROX COMPANY (US) 2008-12-30 US disclosed
US-7183010-B2 Organic light-emitting diode devices with improved operational stability EASTMAN KODAK CORPORATION (US) 2007-02-27 US disclosed
US-20050245428-A1 Hydroscopic polymer gels for easier cleaning RODRIGUES KLIN A 2005-11-03 US disclosed
US-20040076853-A1 Organic light-emitting diode devices with improved operational stability EASTMAN KODAK COMPANY 2004-04-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160141506-A1 NAPHTHO[2,1-b]FLUORANTHENE COMPOUND, ORGANIC LIGHT-EMITTING DEVICE, DISPLAY APPARATUS, LIGHTING APPARATUS, IMAGE FORMING APPARATUS, AND EXPOSING APPARATUS NAP1L1, NR0B2, AFF1 ALDH1A1 479/4885HSD17B10 602/4885MAPK1 1117/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.